Jane J. Zara

Array ( [id] => 6847345 [patent_doc_number] => 20030166512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Protein carrier system for therapeutic oligonucleotides' [patent_app_type] => new [patent_app_number] => 10/365623 [patent_app_country] => US [patent_app_date] => 2003-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9250 [patent_no_of_claims] => 131 [patent_no_of_ind_claims] => 37 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166512.pdf [firstpage_image] =>[orig_patent_app_number] => 10365623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6809532 [patent_doc_number] => 20030199471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-23 [patent_title] => 'Functional chimeric molecules capable of sliding' [patent_app_type] => new [patent_app_number] => 10/361028 [patent_app_country] => US [patent_app_date] => 2003-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 22158 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20030199471.pdf [firstpage_image] =>[orig_patent_app_number] => 10361028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 531685 [patent_doc_number] => 07179796 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-20 [patent_title] => 'Antisense modulation of PTP1B expression' [patent_app_type] => utility [patent_app_number] => 10/360510 [patent_app_country] => US [patent_app_date] => 2003-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30667 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/179/07179796.pdf [firstpage_image] =>[orig_patent_app_number] => 10360510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6822118 [patent_doc_number] => 20030220279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Decreasing cell proliferation by decreasing levels of PP5' [patent_app_type] => new [patent_app_number] => 10/358851 [patent_app_country] => US [patent_app_date] => 2003-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12798 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220279.pdf [firstpage_image] =>[orig_patent_app_number] => 10358851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7355951 [patent_doc_number] => 20040013662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Microbubble compositions and methods for oligonucleotide delivery' [patent_app_type] => new [patent_app_number] => 10/355388 [patent_app_country] => US [patent_app_date] => 2003-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9860 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20040013662.pdf [firstpage_image] =>[orig_patent_app_number] => 10355388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6642257 [patent_doc_number] => 20030212264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Pancreatic cancer genes' [patent_app_type] => new [patent_app_number] => 10/351953 [patent_app_country] => US [patent_app_date] => 2003-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10138 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20030212264.pdf [firstpage_image] =>[orig_patent_app_number] => 10351953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6702139 [patent_doc_number] => 20030225019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Notch1 inhibitors for inducing apoptosis' [patent_app_type] => new [patent_app_number] => 10/348750 [patent_app_country] => US [patent_app_date] => 2003-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31603 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20030225019.pdf [firstpage_image] =>[orig_patent_app_number] => 10348750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 376980 [patent_doc_number] => 07312080 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-25 [patent_title] => 'Plant resistance to insect pests mediated by viral proteins' [patent_app_type] => utility [patent_app_number] => 10/346144 [patent_app_country] => US [patent_app_date] => 2003-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 13386 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/312/07312080.pdf [firstpage_image] =>[orig_patent_app_number] => 10346144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6706301 [patent_doc_number] => 20030153035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Mutated bmp1b receptor as regulator of ovulation rate' [patent_app_type] => new [patent_app_number] => 10/169051 [patent_app_country] => US [patent_app_date] => 2002-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8246 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20030153035.pdf [firstpage_image] =>[orig_patent_app_number] => 10169051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6710945 [patent_doc_number] => 20030170694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Stabilized nucleic acids in gene and drug discovery and methods of use' [patent_app_type] => new [patent_app_number] => 10/327592 [patent_app_country] => US [patent_app_date] => 2002-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 49729 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170694.pdf [firstpage_image] =>[orig_patent_app_number] => 10327592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7201974 [patent_doc_number] => 20040086880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Method of producing nucleic acid molecules with reduced secondary structure' [patent_app_type] => new [patent_app_number] => 10/324409 [patent_app_country] => US [patent_app_date] => 2002-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 24705 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20040086880.pdf [firstpage_image] =>[orig_patent_app_number] => 10324409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6634983 [patent_doc_number] => 20030211583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Egs molecules that specifically downregulae bcl-xl experession' [patent_app_type] => new [patent_app_number] => 10/169324 [patent_app_country] => US [patent_app_date] => 2002-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5597 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211583.pdf [firstpage_image] =>[orig_patent_app_number] => 10169324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6635353 [patent_doc_number] => 20030211610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Antisense inhibition of adam10 expression' [patent_app_type] => new [patent_app_number] => 10/221643 [patent_app_country] => US [patent_app_date] => 2002-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22794 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211610.pdf [firstpage_image] =>[orig_patent_app_number] => 10221643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 509185 [patent_doc_number] => 07195916 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-27 [patent_title] => 'Method for expression of small antiviral RNA molecules within a cell' [patent_app_type] => utility [patent_app_number] => 10/319341 [patent_app_country] => US [patent_app_date] => 2002-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 16 [patent_no_of_words] => 14691 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/195/07195916.pdf [firstpage_image] =>[orig_patent_app_number] => 10319341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 641655 [patent_doc_number] => 07122354 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-17 [patent_title] => 'Nucleic acid encoding a chimeric polypeptide' [patent_app_type] => utility [patent_app_number] => 10/318905 [patent_app_country] => US [patent_app_date] => 2002-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 12923 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 200 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/122/07122354.pdf [firstpage_image] =>[orig_patent_app_number] => 10318905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6843639 [patent_doc_number] => 20030148986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Methods for treating vascular disease by inhibiting myeloid differentiation factor 88' [patent_app_type] => new [patent_app_number] => 10/317992 [patent_app_country] => US [patent_app_date] => 2002-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9527 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20030148986.pdf [firstpage_image] =>[orig_patent_app_number] => 10317992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7304129 [patent_doc_number] => 20040115652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Modulation of TEK expression' [patent_app_type] => new [patent_app_number] => 10/319914 [patent_app_country] => US [patent_app_date] => 2002-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20908 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115652.pdf [firstpage_image] =>[orig_patent_app_number] => 10319914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7290826 [patent_doc_number] => 20040110701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Modulation of zinedin expression' [patent_app_type] => new [patent_app_number] => 10/317270 [patent_app_country] => US [patent_app_date] => 2002-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19914 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110701.pdf [firstpage_image] =>[orig_patent_app_number] => 10317270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7290797 [patent_doc_number] => 20040110698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Oligonucleotides and methods using same for treating cox-ll associated diseases' [patent_app_type] => new [patent_app_number] => 10/315218 [patent_app_country] => US [patent_app_date] => 2002-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11499 [patent_no_of_claims] => 146 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110698.pdf [firstpage_image] =>[orig_patent_app_number] => 10315218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7290828 [patent_doc_number] => 20040110702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Modulation of MAGE-D1 expression' [patent_app_type] => new [patent_app_number] => 10/317278 [patent_app_country] => US [patent_app_date] => 2002-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19323 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110702.pdf [firstpage_image] =>[orig_patent_app_number] => 10317278 [rel_patent_id] =>[rel_patent_doc_number] =>)